Independent, Science-Based Evidence To Empower Canadians

Issue 2023 - Week 01 View this newsletter in your browser

Hello Sonya,

At the Canadian Covid Care Alliance we are dedicated to sharing evidence-based information to empower Canadians to remain safe and healthy.

The speed of science should not be faster than the speed of safety. Emergency authorization for the COVID-19 genetic vaccine rollout was based on preliminary clinical trials. Key issues were overlooked during these trials. This raises questions about their claims of being safe and effective. More importantly, it raises concerns about the validity of the emergency authorization.

Concerning safety signals have been noted since the COVID-19 genetic vaccine rollout. These have also been dismissed. Altogether, this evidence supports a halting of the COVID-19 genetic vaccine program until further analysis are undertaken.

Virus Variants and Vaccine Effectiveness

Why is it difficult to make a vaccine for coronaviruses? Dr Ryan Cole provides testimony for the public hearings of Senator Ron Johnson held on December 7, 2022. He explains that the COVID-19 genetic vaccines are targeting the part of the virus that frequently and rapidly mutates and for that reason, we will always be playing catch up to the newest variant.

View 6-Min Clip

View Full Hearing Video

A Citizens' Hearing Testimony

Brook Jackson, Pfizer whistleblower, was a regional director for one of the COVID-19 genetic vaccine clinical trial sites. During the 3-day Citizens' Hearing in June, 2022, Ms Jackson testified that after reporting breaches in data integrity and quality assurances, she was fired within 18 days of starting her job. She details her experience and concerns here.

Hear Brook's Testimony

Below is an overview of Brook Jackson's data integrity and regulatory oversight concerns in a British Medical Journal (BMJ) Investigation.

BMJ Investigation

Explained: Pfizer's EUA Was Granted Based on Less Than 0.4% of Clinical Trial Participants

Scientists at the Daily Clout have done an initial analysis of the 170 patients who were deemed eligible for the final efficacy analysis in the Pfizer/BioNTech COVID-19 genetic clinical trial. These were the participants whose outcomes resulted in granting the EUA in the US. The team has discovered that many participants did not actually meet eligibility criteria. Other questions about the participants require further investigation. The investigators argue that since not enough participants were eligible, the criteria for the EUA were not met and the EUA should have been revoked.

Read Article

View Analysis

FDA Oversight Critique

COVID-19 genetic vaccines and drugs were developed at "warp speed". Experts are concerned that the US Food and Drug Administration inspected too few clinical trial sites to have a good grasp on the quality of the trials.

BMJ Investigation

Learn more about how you can support this national independent citizen-led inquiry.

Show Support

Apply To Be A Witness

The Canadian Covid Care Alliance is sharing this initiative created by a citizen led group to raise awareness about the topic and to encourage your consideration.

Contact CAERS.

CAERS is an adverse event reporting system separate from government and public health agencies across Canada, determined to provide an accurate depiction of possible adverse events individuals have experienced due to the COVID-19 vaccine inoculation program.

Our alliance of independent Canadian doctors, scientists, health care practitioners, and lawyers is committed to providing top-quality and balanced, evidence-based information to the Canadian public about COVID-19 so that hospitalizations can be reduced, lives saved, and our country safely restored as quickly as possible.

Reach Us Directly At:

info@canadiancovidcarealliance.org

DISCLAIMER

The information contained or presented in this newsletter is for educational purposes only. Information in this newsletter is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a licensed medical professional. The facts presented are offered as information only in order to empower you to make further informed decisions.

Any links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by CCCA of any products, services or opinions of the corporation, organization or individual. The CCCA bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site directly for answers to any question regarding its content.

Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. In no way should anyone infer that we, even though we are physicians, are practicing medicine; it is for educational purposes only. Seek the advice of a medical professional for proper application of ANY material in this email to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services (911).

CLAUSE DE NON-RESPONSABILITÉ

Les informations contenues ou présentées dans ce courriel sont uniquement destinées à des fins éducatives. L'information contenue dans ce courriel n'est PAS destinée à remplacer le diagnostic, le traitement ou les conseils d'un professionnel de la santé agréé.

Les faits présentés sont offerts à titre d'information uniquement afin de vous permettre de prendre des décisions plus éclairées. Tous les liens sont fournis à titre de commodité et à des fins d'information seulement; ils ne constituent pas un appui ou une approbation par l’Alliance canadienne pour la prévention et la prise-en charge de la Covid (CCCA) de tout produit, service ou opinion de la société, de l'organisation ou de l'individu. Le CCCA n'est pas responsable de l'exactitude, de la légalité ou du contenu du site externe ou de celui des liens subséquents. Communiquez directement avec le site externe pour obtenir des réponses à toute question concernant son contenu.

Tout protocole de traitement que vous entreprenez doit être discuté avec votre médecin ou un autre professionnel de la santé agréé. En aucun cas, quiconque ne doit déduire que nous, même si nous sommes médecins, pratiquons la médecine; ce site est uniquement destiné à des fins éducatives. Demandez l'avis d'un professionnel de la santé pour l'application correcte de TOUT le contenu de ce courriel à votre situation particulière. N'arrêtez ou ne modifiez JAMAIS vos médicaments sans consulter votre médecin. En cas d'urgence, contactez les services d'urgence (911).